Gastroenterology
Volume 137, Issue 3 , Pages 841-849.e1, September 2009

Reversal of a Virtual Lesion in Human Pharyngeal Motor Cortex by High Frequency Contralesional Brain Stimulation

  • Samantha Jefferson

      Affiliations

    • School of Translational Medicine - GI Sciences, Salford Royal Hospital, University of Manchester, Salford, England
  • ,
  • Satish Mistry

      Affiliations

    • School of Translational Medicine - GI Sciences, Salford Royal Hospital, University of Manchester, Salford, England
  • ,
  • Emilia Michou

      Affiliations

    • School of Translational Medicine - GI Sciences, Salford Royal Hospital, University of Manchester, Salford, England
  • ,
  • Salil Singh

      Affiliations

    • School of Translational Medicine - GI Sciences, Salford Royal Hospital, University of Manchester, Salford, England
  • ,
  • John C. Rothwell

      Affiliations

    • Sobell Department of Neurophysiology, Institute of Neurology, UCL, London, England
  • ,
  • Shaheen Hamdy

      Affiliations

    • School of Translational Medicine - GI Sciences, Salford Royal Hospital, University of Manchester, Salford, England
    • Corresponding Author InformationReprint requests Address requests for reprints to: Shaheen Hamdy, MD, FRCP, PhD, Department of GI Sciences, University of Manchester, Clinical Sciences Building, Salford Royal Hospital, Salford, M6 8HD, England. fax: (44) 161 206 4364

Received 12 March 2009; accepted 27 April 2009. published online 08 May 2009.

Background & Aims

Excitatory brain stimulation with repetitive transcranial magnetic stimulation (rTMS) has been proposed as a treatment for dysphagia after stroke. Moreover, 1-Hz rTMS can induce a “virtual lesion” in the human pharyngeal motor cortex that suppresses brain activity and temporarily disrupts swallowing. We thus examined if rTMS could reverse the disrupted brain and swallowing functions following a unilateral virtual lesion in the pharyngeal motor cortex, such that rTMS might be developed as a therapy.

Methods

Healthy subjects (n = 23) were given varying conditions of 5-Hz rTMS over the pharyngeal motor cortex to determine the most effective excitatory parameters. Thereafter, a unilateral virtual lesion was made in the pharyngeal motor cortex using 1-Hz rTMS, followed by contralateral active or sham 5-Hz rTMS. Motor evoked potentials and serial swallowing reaction times were recorded before and for 60 minutes postlesion to assess reversibility of the disruption to the brain and swallowing.

Results

The greatest increase in pharyngeal motor cortex excitability was seen following 250 pulses of 5-Hz rTMS (F(1,11) = 10.3, P = .008), an effect that lasted over 2 hours. In contrast to sham rTMS, active contralateral 5-Hz rTMS completely abolished the cortical suppression induced by the virtual lesion, with effects occurring for up to 50 minutes in both unlesioned (F(1,11) = 6, P = .03) and lesioned (F(1,11) = 67, P < .001) hemispheres. Active rTMS also reversed the changes in swallowing behavior (F(1,8) = 9, P = .018), restoring function to prelesional levels.

Conclusions

Contralesional-targeted neurostimulation modulates brain activity and swallowing motor behavior after experimental disruption and might be usefully applied in stroke-affected patients as a therapy for dysphagia.

Abbreviations used in this paper: EMG, electromyographic, GABA, γ-aminobutyric acid, ICF, intracortical facilitation, ICI, intracortical inhibition, MEP, motor evoked potential, rTMS, repetitive transcranial magnetic stimulation, TMS, transcranial magnetic stimulation

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Conflicts of interest The authors disclose no conflicts.

 Funding Supported by the Stroke Association (TSA2004/03), Action Medical Research (AP1091), The Wellcome Trust (WT081741MA), and the Medical Research Council (G0400979).

PII: S0016-5085(09)00736-7

doi:10.1053/j.gastro.2009.04.056

Gastroenterology
Volume 137, Issue 3 , Pages 841-849.e1, September 2009